Attached files
| file | filename |
|---|---|
| EX-31.1 - SECTION 302 CERTIFICATION EXHIBIT - NUTRA PHARMA CORP | exh31_1.htm |
| 10-Q - FORM 10-Q - NUTRA PHARMA CORP | a14085.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Nutra Pharma Corp., (the "Company") on Form 10-Q for the quarterly period ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Rik J Deitsch, the Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: November 20, 2017 |
|
/s/ Rik J. Deitsch |
Rik J. Deitsch |
Chief Executive Officer and Chief Financial Officer |